Field & Main Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Field & Main Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.8K	Hold	100	–	–	﹤0.01%	220
2025 Q4	$12.2K	Hold	100	–	–	﹤0.01%	226
2025 Q3	$10K	Hold	100	–	–	﹤0.01%	227
2025 Q2	$8.29K	Hold	100	–	–	﹤0.01%	224
2025 Q1	$8.11K	Hold	100	–	–	﹤0.01%	224
2024 Q4	$9.01K	Hold	100	–	–	﹤0.01%	228
2024 Q3	$9.88K	Hold	100	–	–	﹤0.01%	223
2024 Q2	$9.27K	Hold	100	–	–	﹤0.01%	228
2024 Q1	$9.49K	Hold	100	–	–	﹤0.01%	227
2023 Q4	$8.93K	Hold	100	–	–	﹤0.01%	225
2023 Q3	$7.3K	Hold	100	–	–	﹤0.01%	230
2023 Q2	$8.32K	Hold	100	–	–	﹤0.01%	231
2023 Q1	$7.62K	Hold	100	–	–	﹤0.01%	231
2022 Q4	$8.3K	Hold	100	–	–	0.01%	236
2022 Q3	$8K	Buy	+100	New	+$8.43K	0.01%	236

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Field & Main Bank's XBI Position: Q1 2026 in Review

Field & Main Bank held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 100 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #220.

Field & Main Bank first reported a position in XBI in Q3 2022 and has held it in 15 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Field & Main Bank held 100 shares of State Street SPDR S&P Biotech ETF worth $12.8K as of Q1 2026.
Field & Main Bank left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Field & Main Bank's portfolio in Q1 2026, its #220 holding.
Field & Main Bank first reported a position in State Street SPDR S&P Biotech ETF in Q3 2022 and has held it in 15 quarters since.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Field & Main Bank's 13F filing for Q1 2026, filed 10 Apr 2026.